SOLENO THERAPEUTICS INC
Rank #219HypergrowthSLNO
SOLENO THERAPEUTICS INC (SLNO) — Rank #219 by gross profitability (GP/assets 0.31) · ROE 4.2% · Piotroski F-Score N/A.
As-of 2026-09-15 · CIK 0001484565 · all metrics point-in-time as of the filing date.
About
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
Segments
A revenue-by-segment breakdown is not available for SLNO. This is expected for a single-reportable-segment filer with no product/service revenue disaggregation, or for a company whose filings predate SEC’s XBRL viewer.